Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.68 | N/A |
| PEG Ratio (TTM) | -4.68 | N/A |
| P/S Ratio (TTM) | 3.60 | N/A |
| P/B Ratio (TTM) | 1.17 | N/A |
| P/FCF Ratio (TTM) | -183.90 | N/A |
| Price to 5YR AVG Earnings Ratio | 8.01 | N/A |
| Price to 5YR AVG FCF Ratio | 12.95 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.71% | N/A |
| ROE (TTM) | 8.03% | N/A |
| Net Profit Margin (TTM) | 24.95% | N/A |
| ROIC 5YR AVG | 13.26% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.01% | 21.43% | 10.01% |
| Revenue | 0.02% | 3.51% | 3.17% |
| Net Income | 13.98% | 13.80% | 4.76% |
| Cash Flow | -14.12% | -33.71% | 144.38% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.24 | N/A |
| Quick Ratio (TTM) | 6.24 | N/A |
| D/E Ratio (TTM) | 1.13 | N/A |
| Interest Coverage (TTM) | 0.40 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.40 | N/A |
| LTL to 5YR AVG FCF | 11.51 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.45% | N/A |